Pharmacotherapy of pathological gambling: review of new treatment modalities.
Pathological gambling is classified in the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition as an impulse-control disorder. In the International Classification of Diseases of the WHO, pathological gambling is coded under the heading of 'Habit and Impulse Disorders'. Pathological gambling is a chronic, progressive disorder, which has a prevalence of 1-3.4% among western civilizations. The enormous personal and social consequences of this disorder include a high rate of suicide attempts, job loss, marital and family problems, legal problems, and criminal behavior. Recent studies have demonstrated that pathological gambling patients respond well to treatment with selective serotonin reuptake inhibitors, mood stabilizers and opioid antagonists. These findings support the idea that pathological gambling and other disorders of impulse control may be conceptualized as part of the obsessive-compulsive spectrum disorders or addictive disorders. This article will discuss possible treatment strategies according to different behavior patterns in pathological gambling and also remind the physicians who intend to treat this disorder of the possible diagnosis of pathological gambling.
Lowengrub
Katherine
K
Ness Ziona and Beer Ya'akov Medical Complex and Tel Aviv University, The Rehovot Community Mental Health & Rehabilitation Center, Remez Street 80, Rehovot, 76449, Israel. jalow@netvision.net.il
Iancu
Iulian
I
Aizer
Anat
A
Kotler
Moshe
M
Dannon
Pinhas N
PN
D000928:Antidepressive Agents / Q000627:therapeutic use*; D016739:Behavior, Addictive / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000639:trends; D004358:Drug Therapy / Q000379:methods* / Q000639:trends*; D005715:Gambling; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians' / Q000639:trends; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D009292:Narcotic Antagonists; D017367:Selective Serotonin Reuptake Inhibitors